Tumale, Glysa B.
HRN: 26-34-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 1.5GM (VIAL)
06/24/2025
06/25/2025
IV
1.5 Grams
Q8
SP 1LTCS
Checking Initial Appropriateness